amazing news,,,,,!!!Hopefully, people tak3 the time to appreciate the fast track designation, of ONCs Pelareorep, for Panc cancer.
That in of itself does not end the story. It does obviously add another chapter to the story Onc can read to Roche in negotiations.
keep in mind, there will be additional news next week @ the San Antonio breast cancer symposium.
meaning Onc is starting to fire on all cylinders for the first time in a long time.
A company with TWO cancer fast track designations & multiple collaborations, could be & should be worth billions.
Onc is now in a much stronger negotiation position.